Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the incidence of complete and partial response
and the duration of response in patients with Langerhans Cell Histiocytosis (LCH) treated
with sequential administration of oral 6-Thioguanine (6-TG) after Methotrexate (MTX).